Skip to main content
. 2021 Aug 17;53(3):449–462. doi: 10.3947/ic.2021.0015

Figure 1. Evolutive trends between the two study periods.

Figure 1

Blue, No significant differences; Green, Significant decrease; Red, Significant increase.

M, medicine department; S, surgery department; I, intensive care unit; O, overall data; Ef, Enterococcus faecium; Sa, Staphylococcus aureus; Kp, Klebsiella pneumoniae; Ab, Acinetobacter baumannii; Pa, Pseudomonas aeruginosa; Ent, Enterobacter spp.; PEN, penicillin; AMP, ampicillin; OXA, oxacillin; CFZ, cefazolin; CTX, cefotaxime; CRO, ceftriaxone; CAZ, ceftazidime; FEP, cefepime; AMC, amoxicillin-clavulanic; SAM, ampicillin-sulbactam; TZP, piperacillin-tazobactam; ATM, aztreonam; IPM, imipenem; MEM, meropenem; ETP, ertapenem; GEN, gentamicin; AMK, amikacin; STR, streptomycin; TET, tetracycline; RIF: rifampicin; CIP, ciprofloxacin; ERY, erythromycin; CLI, clindamycin; TMP/SMX, trimethoprim-sulfamethoxazole; VAN, vancomycin.